Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NDF-RT |
N0000175670
Created by
admin on Wed Apr 02 01:56:10 GMT 2025 , Edited by admin on Wed Apr 02 01:56:10 GMT 2025
|
||
|
LIVERTOX |
NBK548768
Created by
admin on Wed Apr 02 01:56:10 GMT 2025 , Edited by admin on Wed Apr 02 01:56:10 GMT 2025
|
||
|
FDA ORPHAN DRUG |
135600
Created by
admin on Wed Apr 02 01:56:10 GMT 2025 , Edited by admin on Wed Apr 02 01:56:10 GMT 2025
|
||
|
WHO-VATC |
QM04AX02
Created by
admin on Wed Apr 02 01:56:10 GMT 2025 , Edited by admin on Wed Apr 02 01:56:10 GMT 2025
|
||
|
NCI_THESAURUS |
C921
Created by
admin on Wed Apr 02 01:56:10 GMT 2025 , Edited by admin on Wed Apr 02 01:56:10 GMT 2025
|
||
|
WHO-ATC |
M04AX02
Created by
admin on Wed Apr 02 01:56:10 GMT 2025 , Edited by admin on Wed Apr 02 01:56:10 GMT 2025
|
||
|
EMA ASSESSMENT REPORTS |
KRYSTEXXA (AUTHORIZED: GOUT)
Created by
admin on Wed Apr 02 01:56:10 GMT 2025 , Edited by admin on Wed Apr 02 01:56:10 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL1237025
Created by
admin on Wed Apr 02 01:56:10 GMT 2025 , Edited by admin on Wed Apr 02 01:56:10 GMT 2025
|
PRIMARY | |||
|
1011650
Created by
admin on Wed Apr 02 01:56:10 GMT 2025 , Edited by admin on Wed Apr 02 01:56:10 GMT 2025
|
PRIMARY | RxNorm | ||
|
R581OT55EA
Created by
admin on Wed Apr 02 01:56:10 GMT 2025 , Edited by admin on Wed Apr 02 01:56:10 GMT 2025
|
PRIMARY | |||
|
7463
Created by
admin on Wed Apr 02 01:56:10 GMT 2025 , Edited by admin on Wed Apr 02 01:56:10 GMT 2025
|
PRIMARY | |||
|
100000124526
Created by
admin on Wed Apr 02 01:56:10 GMT 2025 , Edited by admin on Wed Apr 02 01:56:10 GMT 2025
|
PRIMARY | |||
|
XX-121
Created by
admin on Wed Apr 02 01:56:10 GMT 2025 , Edited by admin on Wed Apr 02 01:56:10 GMT 2025
|
PRIMARY | |||
|
SUB32159
Created by
admin on Wed Apr 02 01:56:10 GMT 2025 , Edited by admin on Wed Apr 02 01:56:10 GMT 2025
|
PRIMARY | |||
|
8934
Created by
admin on Wed Apr 02 01:56:10 GMT 2025 , Edited by admin on Wed Apr 02 01:56:10 GMT 2025
|
PRIMARY | |||
|
C97466
Created by
admin on Wed Apr 02 01:56:10 GMT 2025 , Edited by admin on Wed Apr 02 01:56:10 GMT 2025
|
PRIMARY | |||
|
R581OT55EA
Created by
admin on Wed Apr 02 01:56:10 GMT 2025 , Edited by admin on Wed Apr 02 01:56:10 GMT 2025
|
PRIMARY | |||
|
5176
Created by
admin on Wed Apr 02 01:56:10 GMT 2025 , Edited by admin on Wed Apr 02 01:56:10 GMT 2025
|
PRIMARY | |||
|
885051-90-1
Created by
admin on Wed Apr 02 01:56:10 GMT 2025 , Edited by admin on Wed Apr 02 01:56:10 GMT 2025
|
PRIMARY | |||
|
m8447
Created by
admin on Wed Apr 02 01:56:10 GMT 2025 , Edited by admin on Wed Apr 02 01:56:10 GMT 2025
|
PRIMARY | Merck Index | ||
|
PEGLOTICASE
Created by
admin on Wed Apr 02 01:56:10 GMT 2025 , Edited by admin on Wed Apr 02 01:56:10 GMT 2025
|
PRIMARY | |||
|
DB09208
Created by
admin on Wed Apr 02 01:56:10 GMT 2025 , Edited by admin on Wed Apr 02 01:56:10 GMT 2025
|
PRIMARY |
ACTIVE MOIETY